Treatment for basal cell carcinoma
US7696159B2 · kind B2 · utility
58Cited by
72References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2008 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Jan 23, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.